Search Medical Condition
Please enter condition
Please choose location from dropdown

St. Joseph, Missouri Clinical Trials

A listing of St. Joseph, Missouri clinical trials actively recruiting patient volunteers.

RESULTS

Found (101) clinical trials

Study to evaluate the safety and effectiveness, and the potential for adrenal suppression, with the use of Topicort Topical Spray 0.25% in pediatric patients with plaque psoriasis.

Phase N/A

2.71 miles

Learn More »

A study to evaluate safety and effectiveness of Asimadoline in adult subjects with eczema (atopic dermatitis).

Phase N/A

2.71 miles

Learn More »

A study to evaluate the safety and effectiveness of a new, unmarketed, version of Tacrolimus Ointment 0.1% compared to Protopic 0.1% or a placebo ointment in subjects with eczema (atopic dermatitis).

Phase N/A

2.71 miles

Learn More »

Study to evaluate the safety and effectiveness of a generic Pimecrolimus Cream 1%, to Elidel Cream 1% and to placebo cream, when used in subjects with eczema (atopic dermatitis).

Phase N/A

2.71 miles

Learn More »

Study to evaluate the safety and effectiveness of DRM04 Topical Wipes, 3.75% in subjects with excessive underarm sweat (axillary hyperhydrosis).

Phase N/A

2.71 miles

Learn More »

This is a multicenter clinical study to learn about the safety and efficacy of the application of a silver suspension to the skin prior to laser treatment to remove light-colored hair. One side of the treatment area will have the silver suspension applied prior to laser treatment, and the other ...

Phase N/A

2.71 miles

Learn More »

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

PRIMARY OBJECTIVES: I. To evaluate the objective response rate (confirmed and unconfirmed, complete and partial) by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 among patients treated with durvalumab (MEDI4736) plus tremelimumab. SECONDARY OBJECTIVES: I. To estimate the duration of response (DoR) among patients who achieve a complete response (CR) ...

Phase

2.71 miles

Learn More »

Cisplatin Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery

PRIMARY OBJECTIVES: I. To assess the progression free survival (PFS) of platinum (cisplatin or carboplatin) and etoposide versus the PFS of temozolomide and capecitabine in patients with advanced G3 non-small cell gastroenteropancreatic neuroendocrine carcinomas. SECONDARY OBJECTIVES: I. To assess the response rate (RR) of platinum (cisplatin or carboplatin) and etoposide ...

Phase

2.71 miles

Learn More »

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

PRIMARY OBJECTIVES: I. To assess 2-year overall survival in each treatment arm (fluorouracil, irinotecan hydrochloride, and oxaliplatin [modified (m)FOLFIRINOX] and gemcitabine [gemcitabine hydrochloride]/nab-paclitaxel [paclitaxel albumin-stabilized nanoparticle formulation]) in patients with resectable pancreatic cancer. II. If the stated threshold is met in one or both arms: to choose the better regimen ...

Phase

2.71 miles

Learn More »

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

PRIMARY OBJECTIVES: I. To determine whether the addition of carboplatin to an adjuvant chemotherapy regimen of doxorubicin (doxorubicin hydrochloride)/cyclophosphamide followed by paclitaxel will improve the invasive disease-free survival (IDFS) compared to doxorubicin/cyclophosphamide followed by paclitaxel when administered to patients with operable node-positive or high-risk node-negative triple-negative breast cancer. SECONDARY OBJECTIVES: ...

Phase

2.71 miles

Learn More »